Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism
about
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsSynapses as therapeutic targets for autism spectrum disorders: an international symposium held in pavia on july 4th, 2014The fragile X syndrome-autism comorbidity: what do we really know?Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.Postsynaptic mGluR5 promotes evoked AMPAR-mediated synaptic transmission onto neocortical layer 2/3 pyramidal neurons during developmentIdentification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain.Elevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.CNS autoimmune disease after Streptococcus pyogenes infections: animal models, cellular mechanisms and genetic factors.Sex differences in cerebellar synaptic transmission and sex-specific responses to autism-linked Gabrb3 mutations in mice.Clinical and Molecular Assessment in a Female with Fragile X Syndrome and Tuberous Sclerosis.Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.Genetic findings in obsessive-compulsive disorder connect to brain-derived neutrophic factor and mammalian target of rapamycin pathways: implications for drug development.The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic reviewOxytocin: parallel processing in the social brain?Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics.Modeling Fragile X syndrome in neurogenesis: An unexpected phenotype and a novel tool for future therapies.Group I Metabotropic Glutamate Receptor Interacting Proteins: Fine-Tuning Receptor Functions in Health and Disease.Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome.Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.Prenatal bisphenol A (BPA) exposure alters the transcriptome of the neonate rat amygdala in a sex-specific manner: a CLARITY-BPA consortium study.Nuclear Excluded Autism-Associated Phosphatase and Tensin Homolog Mutations Dysregulate Neuronal Growth.Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease.The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum.Targeting mGlu5 Metabotropic Glutamate Receptors in the Treatment of Cognitive Dysfunction in a Mouse Model of Phenylketonuria.Increased Axonal Bouton Stability during Learning in the Mouse Model of MECP2 Duplication Syndrome
P2860
Q26998975-7E3C4FD4-A49B-43FF-BAA0-A180907807FFQ27318675-83664BAE-C618-434E-9D35-C72E67C53B68Q28077671-3D78EEA4-0022-4488-BC3B-B56DBBF644CBQ34264917-DBE8CA89-BEF6-43B7-8A65-00A7FEFD48F6Q34349515-7EEFC349-90C3-420A-B27F-C6831B3042D9Q34573953-4AC565D2-DF73-416B-B943-FA0DB70408EEQ35034977-1A8B4A07-EF33-4B04-A966-6502530F601CQ35575400-7D53AA3F-E451-481C-8927-FC135A817827Q35821450-EF63E49E-6ACE-43B4-A1DF-274AF5C93AFEQ36387172-9FF78861-6FA6-4559-AB6D-25E43F47D72FQ36822034-3BA54438-48F4-4317-A4C2-A66796D17200Q36932106-1B6E0C5F-D0E1-4591-A64B-5F523DC45D75Q37656557-54F93557-7CE7-47F0-8095-7B1548BB58CEQ37694175-CEC42C87-99FA-46F3-B1F7-1C6405C42FC3Q38246625-436E0506-321E-42F5-8E5E-99AC39ABB9F5Q38247298-91D64B9D-AD13-45D8-B3AE-B827E9A750BDQ38442124-43427BA1-00AE-41DF-9A69-482476570747Q38607739-0AB89646-2731-43C0-ABDF-CACD09F2B1FFQ38716262-362C240D-B168-42DD-90CD-B7012AC1E2DDQ38863889-766D5145-EE93-4B11-B6FF-A11D7D3E33CBQ40562510-A389F588-6F11-49F7-981C-0483896E1D76Q42057101-B4E2F599-5DDA-42DD-A4DF-390C477E47E7Q42098963-3B141FAF-DAB8-4BF9-801A-855C781E92A3Q42645980-9DAFEE2D-84A5-4986-8374-7B7A52AEEEEEQ44876732-B5E26356-5680-40CC-AE2C-EAE7065AC3FDQ47548720-CAAA515F-E344-42D5-81CF-C6258D3D48D5Q47752204-67B0B8DC-33E4-4B99-9C81-44F9D08F067AQ47766445-F644BFCD-6165-4A71-A794-68608B75E3C3Q55352164-075B4AAB-E1D0-4068-8CFF-1ACA6DCEDD31Q58791387-915EC096-7D63-478D-99DA-713AAFD86A3E
P2860
Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Dysregulation of group-I metab ...... llectual Disability and Autism
@ast
Dysregulation of group-I metab ...... llectual Disability and Autism
@en
type
label
Dysregulation of group-I metab ...... llectual Disability and Autism
@ast
Dysregulation of group-I metab ...... llectual Disability and Autism
@en
prefLabel
Dysregulation of group-I metab ...... llectual Disability and Autism
@ast
Dysregulation of group-I metab ...... llectual Disability and Autism
@en
P2860
P50
P1476
Dysregulation of group-I metab ...... llectual Disability and Autism
@en
P2093
Kimberly M Huber
Michela Spatuzza
P2860
P304
P356
10.1016/J.NEUBIOREV.2014.02.003
P478
P50
P577
2014-02-15T00:00:00Z